Indian Journal of Drugs in Dermatology

CASE REPORT
Year
: 2019  |  Volume : 5  |  Issue : 1  |  Page : 34--37

Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations


Pooja Bains, Saurabh Sharma 
 Department of Skin and V.D, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India

Correspondence Address:
Dr. Pooja Bains
Department of Skin and V.D, Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar, Punjab
India

Sorafenib is a multikinase inhibitor which is used in the treatment of hepatocellular carcinoma and renal cell carcinoma. The cutaneous toxicities due to sorafenib can affect the daily activities of patients, resulting in interruption or dose modification of therapy. We report four cases of adverse cutaneous effects of sorafenib along with their management. The cases represent the wide spectrum of sorafenib cutaneous toxicities from mild to severe.


How to cite this article:
Bains P, Sharma S. Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations.Indian J Drugs Dermatol 2019;5:34-37


How to cite this URL:
Bains P, Sharma S. Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations. Indian J Drugs Dermatol [serial online] 2019 [cited 2024 Mar 29 ];5:34-37
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=34;epage=37;aulast=Bains;type=0